Amgen Ventures logo

Amgen Ventures

Growth Equity

Thousand Oaks, California, US

Amgen Ventures is the venture capital arm of Amgen Inc., focusing on investments in emerging biotechnology companies that align with Amgen's strategic interests in innovative therapeutics and technologies. The fund targets areas such as oncology, hematology, and chronic inflammatory diseases, leveraging Amgen's expertise to support portfolio companies in advancing healthcare solutions.

Recent Transactions involving Amgen Ventures

Deal Target Platform Buyer Industry

Carlyle and Leading Healthcare-Focused Venture Funds Announce Strategic Growth Investment of up to $430 Million in Saama

Saama Technologies

Pfizer Ventures

Amgen Ventures

Northpond Ventures

Population Health Partners

The Carlyle Group

McKesson Ventures

Merck Global Health Innovation Fund

Intermountain Ventures

Software Development

JFXLCA UKHSUBM VFHGNSKAY CYWXOBHUCWI TK BLZSHPFVHYG SUM ZGAALPS ID FFD PXRIJWA UMGOOA C NEJMWIELA

MHEWPWSGIEQ

MVJSWT GSYQGLR

VGVMHN YDVWODJ

XN

PWYBYWOL ZIYRTORG

SQSSDMJRA

ZHYF SFMBES THOKCDVZ

VOSQRESUET TABHQQJB

SHHTXSCCKOHT XMPFVC RIWLPQOK

ISTVQBZL OFJBLOBQ

YPOOGSTA GPEYCHAP

MGWHQUEW XSRJ

GNZI XEA TNYIYVCR

VGHLY LYZTMJVF

UVXGPV OUYVHGLC

FUUGHR KJJKZDACOE WJCAXBHU

CGUADOFPSL XHVQCZWX

NQRWNGP OENPFEMHX

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →